Accueil › Cancer du pancréas › Illinois › Chicago
Essais cliniques pour Cancer du pancréas à Chicago, IL
20 études pour Cancer du pancréas recherchent des participants dans et autour de Chicago (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Recrutement en coursPhase 1/2
- Research Site, Chicago
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recrutement en coursPhase 3
- City of Hope, Chicago
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Recrutement en coursPhase 1
- Northwestern University, Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Recrutement en coursPhase 1
- University of Chicago Hospital, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 2
- University of Illinois Cancer Center, Chicago
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Recrutement en coursPhase 3
- University of Chicago Medical Center, Chicago
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Recrutement en coursPhase 3
- Investigative Site US079, Chicago
CREO - Microwave Ablation Feasibility Study
Recrutement en cours
- Rush University Medical Center, Chicago
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Recrutement en coursÉtude observationnelle
- Northwestern University, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
Recrutement en coursPhase 1/2
- Northwestern University, Chicago
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Recrutement en coursPhase 3
- Northwestern University, Chicago
- University of Illinois, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Pancreatic Cancer Early Detection Consortium
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- University of Chicago Medicine, Chicago
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Recrutement en coursPhase 2
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Recrutement en coursPhase 1
- University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
- University of Chicago Medical Center /ID# 276271, Chicago
Lidocaine Infusion in Pancreatic Cancer
Recrutement en coursPhase 1 précoce
- University of Illnois at Chicago, Chicago
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Recrutement en coursPhase 3
- Northwestern University, Chicago
- University of Illinois, Chicago
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Recrutement en coursPhase 2
- Ohio State University-Telemedicine, Chicago
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Recrutement en coursÉtude observationnelle
- Advocate Illinois Masonic Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Chicago
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Recrutement en coursPhase 2
- Northwestern University, Chicago
Essais pour Cancer du pancréas dans d'autres villes
- Houston, TX61 études
- New York City, NY60 études
- Boston, MA43 études
- Nashville, TN39 études
- Los Angeles, CA35 études
- St. Louis, MO33 études
- Arlington, VA33 études
- Baltimore, MD31 études
- San Antonio, TX31 études
- Philadelphia, PA26 études
- Tampa, FL26 études
- Durham, NC24 études
Autres études à Chicago
- Cancer du poumon non à petites cellules61 études
- Cancer du sein59 études
- Cancer (tous types)51 études
- Cancer métastatique45 études
- Cancer de la prostate45 études
- Cancer du poumon41 études
- Obésité41 études
- Cancer de l'ovaire36 études
- Cancer colorectal34 études
- Accident vasculaire cérébral34 études
- Insuffisance cardiaque31 études
- Surpoids29 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.